Advertisement

Reactions Weekly

, Volume 1780, Issue 1, pp 94–94 | Cite as

Carboplatin/paclitaxel

Massive haemoptysis due to Bacillus cereus necrotising pneumonia: case report
Case report
  • 72 Downloads
Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

  • * death

  • * life-threatening

  • * hospitalisation

  • * disability

  • * congenital anomaly

  • * other medically important event

A 59-year-old man developed massive haemoptysis due to Bacillus cereus necrotising pneumonia while receiving immunosuppressive therapy with carboplatin and paclitaxel for oesophageal adenocarcinoma [duration of treatments to reactions onsets not stated].

The man, who had stage IIIa distal oesophageal adenocarcinoma, started receiving neoadjuvant radiation and chemotherapy with paclitaxel and carboplatin [dosages and routes not stated]. Subsequently, he presented to an emergency department (ED) with sudden onset of haemoptysis (approximately 200mL). He rapidly developed epigastric pain, nausea and a history of retching coinciding with the haemoptysis. His initial vital signs were as follows: temperature 39.2C, BP 90/65mm Hg, heart rate (HR) 147 bpm, 18 respirations/min and...

Reference

  1. Leung EC, et al. An unusual case of massive hemoptysis due to Bacillus cereus necrotizing pneumonia. Respiratory Medicine Case Reports 28: 100943, 2019. Available from: URL: http://doi.org/10.1016/j.rmcr.2019.100943 - CanadaCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations